Literature DB >> 33009508

The changing face of gastric cancer: epidemiologic trends and advances in novel therapies.

Raghav Chandra1, Neeraja Balachandar2, Sam Wang1, Scott Reznik3, Herbert Zeh1, Matthew Porembka4.   

Abstract

Gastric cancer is an aggressive solid-tumor malignancy with poor prognosis. The epidemiologic face of gastric cancer is changing and further insight into its heterogenous immunohistopathologic nature is needed to develop personalized therapies for specific patient populations. In this review, we highlight changes in gastric cancer epidemiology with a special emphasis on racial and ethnic variations and discuss the implications of current clinical and preclinical treatment advances.

Entities:  

Mesh：

Year:  2020        PMID： 33009508     DOI： 10.1038/s41417-020-00234-z

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN： 0929-1903            Impact factor:   5.987


  86 in total

1.  Gastric cancer: two epidemics?

Authors:  Pelayo Correa
Journal:  Dig Dis Sci       Date:  2011-05       Impact factor: 3.199

2.  A rising trend in the incidence of advanced gastric cancer in young Hispanic men.

Authors:  Shaila J Merchant; Joseph Kim; Audrey H Choi; Virginia Sun; Joseph Chao; Rebecca Nelson
Journal:  Gastric Cancer       Date:  2016-02-29       Impact factor: 7.370

3.  Gastric cancer in the young: An advanced disease with poor prognostic features.

Authors:  Kais A Rona; Katrin Schwameis; Joerg Zehetner; Kamran Samakar; Kyle Green; Jamil Samaan; Kulmeet Sandhu; Nikolai Bildzukewicz; Namir Katkhouda; John C Lipham
Journal:  J Surg Oncol       Date:  2016-12-23       Impact factor: 3.454

4.  Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities.

Authors:  Yonatan H Grad; Marc Lipsitch; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2011-11-15       Impact factor: 4.897

5.  Gastric adenocarcinoma in young patients: a population-based appraisal.

Authors:  Waddah B Al-Refaie; Chung-Yuan Hu; Peter W T Pisters; George J Chang
Journal:  Ann Surg Oncol       Date:  2011-03-22       Impact factor: 5.344

6.  Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992-2009 SEER data.

Authors:  Felix H Lui; Bertrand Tuan; Sara L Swenson; Robert J Wong
Journal:  Dig Dis Sci       Date:  2014-07-17       Impact factor: 3.199

7.  Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.

Authors:  Sam C Wang; Yunku Yeu; Tae Hyun Hwang; Matthew R Porembka; Suntrea T G Hammer; Shu Xiao; Min Zhu; Changjin Hong; Jean R Clemenceau; Lynn Y Yoon; Ibrahim Nassour; Jeanne Shen; Deepak Agarwal; Scott I Reznik; John C Mansour; Adam C Yopp; Hao Zhu
Journal:  Cancer Res       Date:  2020-04-08       Impact factor: 12.701

8.  Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?

Authors:  Horacio Noé López-Basave; Flavia Morales-Vásquez; Juan Manuel Ruiz-Molina; Silvio A Namendys-Silva; Itzel Vela-Sarmiento; Javier Melchor Ruan; Alejandro E Padilla Rosciano; German Calderillo-Ruiz; Consuelo Díaz-Romero; Angel Herrera-Gómez; Abelardo A Meneses-García
Journal:  Cancer Manag Res       Date:  2013-04-04       Impact factor: 3.989

9.  Lauren classification and individualized chemotherapy in gastric cancer.

Authors:  Junli Ma; Hong Shen; Linda Kapesa; Shan Zeng
Journal:  Oncol Lett       Date:  2016-03-16       Impact factor: 2.967

10.  CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.

Authors:  Andrea Rebeca Bustos-Carpinteyro; Carla Oliveira; Abel Sousa; Patricia Oliveira; Hugo Pinheiro; Joana Carvalho; María Teresa Magaña-Torres; María Guadalupe Flores-Miramontes; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez; Jorge Peregrina-Sandoval; José Alfonso Cruz-Ramos; Josefina Yoaly Sánchez-López
Journal:  BMC Cancer       Date:  2019-01-14       Impact factor: 4.430
View more
  12 in total

1.  Prognostic role of myeloid-derived tumor-associated macrophages at the tumor invasive margin in gastric cancer with liver metastasis (GCLM): a single-center retrospective study.

Authors:  Zeyu Wang; Zhongyi Dong; Gang Zhao; Bo Ni; Zi-Zhen Zhang
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Ethnic Disparities in Early-Onset Gastric Cancer: A Population-Based Study in Texas and California.

Authors:  Caitlin C Murphy; Amit G Singal; Anna Tavakkoli; Sandi L Pruitt; Anh Q Hoang; Hong Zhu; Amy E Hughes; Thomas A McKey; B Joseph Elmunzer; Richard S Kwon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

3.  miR-153-3p Attenuates the Development of Gastric Cancer by Suppressing SphK2.

Authors:  Zhengwo Jia; Xiaofang Tang; Xicheng Zhang; Jingen Shen; Yuanlong Sun; Lifen Qian
Journal:  Biochem Genet       Date:  2022-01-28       Impact factor: 2.220

4.  Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation.

Authors:  Yuhao Luo; Siting Zheng; Qianying Wu; Jianhua Wu; Rui Zhou; Chunling Wang; Zhenzhen Wu; Xiaoxiang Rong; Na Huang; Li Sun; Jianping Bin; Yulin Liao; Min Shi; Wangjun Liao
Journal:  Autophagy       Date:  2021-03-25       Impact factor: 16.016

Review 5.  Progress in neoadjuvant therapy for gastric cancer.

Authors:  Peng-Fei Su; Jian-Chun Yu
Journal:  Oncol Lett       Date:  2022-04-13       Impact factor: 2.967

Review 6.  Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.

Authors:  Mahdieh Razmi; Roya Ghods; Somayeh Vafaei; Maryam Sahlolbei; Leili Saeednejad Zanjani; Zahra Madjd
Journal:  Cancer Cell Int       Date:  2021-02-27       Impact factor: 5.722

7.  Immune Score Predicts Outcomes of Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy.

Authors:  Wei Zou; Meng-Long Zhou; Ling-Yi Zhang; Jia-Ning Yang; Wang Yang; Ya-Qi Wang; Yu-Xi Yi; Gui-Chao Li; Zhen Zhang
Journal:  J Oncol       Date:  2021-12-27       Impact factor: 4.375

8.  Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer.

Authors:  Jun Lu; Bin-Bin Xu; Li-Li Shen; Dong Wu; Zhen Xue; Hua-Long Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chang-Ming Huang; Chao-Hui Zheng; Ping Li
Journal:  JAMA Netw Open       Date:  2021-09-01

9.  Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.

Authors:  John D Karalis; Lynn Y Yoon; Matthew R Porembka; Sam C Wang; Suntrea T G Hammer; Changjin Hong; Min Zhu; Ibrahim Nassour; Michelle R Ju; Shu Xiao; Esther C Castro-Dubon; Deepak Agrawal; Jorge Suarez; Scott I Reznik; John C Mansour; Patricio M Polanco; Adam C Yopp; Herbert J Zeh; Tae Hyun Hwang; Hao Zhu
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 10.  Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation.

Authors:  Chris M Li; Zhibin Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.